Susquehanna International Group, LLP Renovo Rx, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.3 - $2.3 $2,629 - $4,652	-2,023 Reduced 16.36%	10,340 $13,000
Q2 2023 Aug 11, 2023	BUY	$1.85 - $3.21 $22,871 - $39,685	12,363 New	12,363 $27,000
Q2 2022 Aug 15, 2022	SELL	$1.52 - $2.99 $28,244 - $55,560	-18,582 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.87 - $4.9 $53,330 - $91,051	18,582 New	18,582 $54,000

2.87M

Ticker RNXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,066,860
Market Cap $11.7M
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.